Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accorda ... in Germany

Work Detail

Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.. The Kaufmännische Krankenkasse - Kkh (Hereinafter Kkh) Pursues The Goal Of Entering Into Discount Agreements With All Suitable Pharmaceutical Companies In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient (Atc) Mentioned Under Bt-21-Lot And, If Necessary, Restricting It To Certain Dosage Forms Within The Framework Of A To Complete The So-Called Open House Procedure. Subject To Uniform Contractual Conditions And A Uniform Access Procedure, All Suitable And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Are Offered The Opportunity To Conclude Or Join A Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Above-Mentioned Active Ingredient. Interested Pharmaceutical Companies Can Request The Participation Documents And The Contract From The Contact Address Provided. The Prerequisite For Concluding A Contract Is That The Interested Pharmaceutical Company Submits The Requested Participation Documents, Completely Completed And Signed. A Contract Is Concluded With Each Pharmaceutical Company That Meets The Participation Requirements. There Is No Exclusivity. Joining Or Concluding A Contract Can Take Place At Any Time And Under The Same Conditions. Individual Contract Negotiations Will Not Be Carried Out. If The Kkh Carries Out A Tender For Exclusive Contracts For The Active Ingredients In The Form Of The Open Procedure During The Contract Term, The Contracts Concluded Within The Framework Of This Publication Will Be Terminated In Accordance With The Contractual Regulations.

Contact Information